Literature DB >> 15878710

Residues stabilizing the heme moiety of the nitric oxide sensor soluble guanylate cyclase.

Peter M Schmidt1, Christiane Rothkegel, Frank Wunder, Henning Schröder, Johannes-Peter Stasch.   

Abstract

Soluble guanylate cyclase, a heterodimer consisting of an alpha- and a heme-containing beta-subunit, is the major receptor for the biological messenger nitric oxide (NO) and is involved in various signal transduction pathways. The heme moiety of the enzyme is bound between the axial heme ligand histidine(105) and the recently identified counterparts of the heme propionic acids, tyrosine(135) and arginine(139). The latter residues together with an invariant serine(137) form the unique heme binding motif Y-x-S-x-R. In this work, we show that replacement of the serine(137) with alanine destabilizes the binding of the heme moiety and impairs NO-mediated soluble guanylate cyclase activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15878710     DOI: 10.1016/j.ejphar.2005.02.046

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  15 in total

Review 1.  NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential.

Authors:  Oleg V Evgenov; Pál Pacher; Peter M Schmidt; György Haskó; Harald H H W Schmidt; Johannes-Peter Stasch
Journal:  Nat Rev Drug Discov       Date:  2006-09       Impact factor: 84.694

2.  Aspartate 102 in the heme domain of soluble guanylyl cyclase has a key role in NO activation.

Authors:  Padmamalini Baskaran; Erin J Heckler; Focco van den Akker; Annie Beuve
Journal:  Biochemistry       Date:  2011-05-02       Impact factor: 3.162

3.  Probing the presence of the ligand-binding haem in cellular nitric oxide receptors.

Authors:  B Roy; E Mo; J Vernon; J Garthwaite
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

4.  Insight into the rescue of oxidized soluble guanylate cyclase by the activator cinaciguat.

Authors:  Nur Basak Surmeli; Michael A Marletta
Journal:  Chembiochem       Date:  2012-03-30       Impact factor: 3.164

5.  NO and CO differentially activate soluble guanylyl cyclase via a heme pivot-bend mechanism.

Authors:  Xiaolei Ma; Nazish Sayed; Annie Beuve; Focco van den Akker
Journal:  EMBO J       Date:  2007-01-11       Impact factor: 11.598

6.  Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase.

Authors:  Faye Martin; Padmamalini Baskaran; Xiaolei Ma; Pete W Dunten; Martina Schaefer; Johannes-Peter Stasch; Annie Beuve; Focco van den Akker
Journal:  J Biol Chem       Date:  2010-05-12       Impact factor: 5.157

Review 7.  Carbon monoxide--physiology, detection and controlled release.

Authors:  Stefan H Heinemann; Toshinori Hoshi; Matthias Westerhausen; Alexander Schiller
Journal:  Chem Commun (Camb)       Date:  2014-04-11       Impact factor: 6.222

8.  Insights into BAY 60-2770 activation and S-nitrosylation-dependent desensitization of soluble guanylyl cyclase via crystal structures of homologous nostoc H-NOX domain complexes.

Authors:  Vijay Kumar; Faye Martin; Michael G Hahn; Martina Schaefer; Jonathan S Stamler; Johannes-Peter Stasch; Focco van den Akker
Journal:  Biochemistry       Date:  2013-05-07       Impact factor: 3.162

9.  Haem homeostasis is regulated by the conserved and concerted functions of HRG-1 proteins.

Authors:  Abbhirami Rajagopal; Anita U Rao; Julio Amigo; Meng Tian; Sanjeev K Upadhyay; Caitlin Hall; Suji Uhm; M K Mathew; Mark D Fleming; Barry H Paw; Michael Krause; Iqbal Hamza
Journal:  Nature       Date:  2008-04-16       Impact factor: 49.962

10.  Population pharmacokinetics and pharmacodynamics of cinaciguat, a soluble guanylate cyclase activator, in patients with acute decompensated heart failure.

Authors:  Wolfgang Mueck; Reiner Frey
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.